The COVID-19 vaccine from Pfizer and BioNTech was the first to reach American arms and it accounts for over half of the 380 million doses administered in the U.S. so far.
It enjoys another advantage as the nation hurtles into a period in which workers must choose between getting vaccinated ...
from The Washington Times stories: Health https://ift.tt/3ziYFJ8